These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17323845)

  • 21. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
    Amici G; Orrasch M; Da Rin G; Bocci C
    Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment.
    Floré KM; Fiers T; Delanghe JR
    Clin Chem Lab Med; 2008; 46(12):1763-8. PubMed ID: 19055453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical experience with icodextrin. Multicenter study].
    Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
    Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems.
    Schleis TG
    Pharmacotherapy; 2007 Sep; 27(9):1313-21. PubMed ID: 17723085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive interference of icodextrin metabolites in some enzymatic glucose methods.
    Janssen W; Harff G; Caers M; Schellekens A
    Clin Chem; 1998 Nov; 44(11):2379-80. PubMed ID: 9799776
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.
    Wolfson M; Piraino B; Hamburger RJ; Morton AR;
    Am J Kidney Dis; 2002 Nov; 40(5):1055-65. PubMed ID: 12407652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sterile peritonitis after administration of icodextrin].
    Ekart R; Pecovnik-Balon B; Dvorsak B; Hojs R
    Acta Med Croatica; 2002; 56(4-5):185-7. PubMed ID: 12768899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2005; 21():21-4. PubMed ID: 16686279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple method to determine blood concentration of oligosaccharides in peritoneal dialysis patients using icodextrin.
    Kawase Y; Maeda Y; Yasuda T; Abe K; Miki T
    Perit Dial Int; 2010; 30(3):370-3. PubMed ID: 20424201
    [No Abstract]   [Full Text] [Related]  

  • 32. Peritoneal clearance of homocysteine with icodextrin or standard glucose solution exchange.
    Czupryniak A; Nowicki M; Chwatko G; Jander A; Bald E
    Nephrology (Carlton); 2005 Dec; 10(6):571-5. PubMed ID: 16354239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis.
    Takeguchi F; Nakayama M; Nakao T
    Ther Apher Dial; 2008 Jun; 12(3):243-9. PubMed ID: 18503703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
    Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
    Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal transport characteristics with glucose polymer-based dialysis fluid in children.
    Rusthoven E; Krediet RT; Willems HL; Monnens LA; Schröder CH
    J Am Soc Nephrol; 2004 Nov; 15(11):2940-7. PubMed ID: 15504948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Icodextrin in peritoneal dialysis therapy].
    Grzegorzewska AE; Antczak-Jedrzejczak D
    Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid assay for icodextrin determination in plasma and dialysate.
    Wang R; Moberly JB; Martis L; Shockley TR; Mongoven JW; Patel H; Kunzler J; Hughes G; Gass J
    Adv Perit Dial; 2002; 18():91-5. PubMed ID: 12402596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients.
    Gobin J; Fernando S; Santacroce S; Finkelstein FO
    Blood Purif; 2008; 26(3):279-83. PubMed ID: 18421212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.